Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to access life-changing weight loss medications.

Eli Lilly and Company is conducting a clinical study titled ‘Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research materials to sidestep regulatory scrutiny.

Here’s the unglamorous truth that I’m hesitant to admit: The price tag is a commitment. Tirzepatide isn’t covered by insurance unless you qualify under certain medical conditions — diabetes, for ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain ...

Maridebart cafraglutide (Amgen), also known as MariTide or AMG133, helps patients with obesity—whether or not they also have diabetes—lose substantial amounts of body weight, according to newly ...

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term habits still matter most.

Click to read the study in AIM Relevant Reading: Tirzepatide once weekly for the treatment of obesity In-Depth [randomized controlled trial]: This post-hoc analysis of SURMOUNT-1, a phase 3, ...